InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: georgejjl post# 214486

Sunday, 01/28/2018 8:20:24 PM

Sunday, January 28, 2018 8:20:24 PM

Post# of 403325
Thank you once again George for posting the facts.

Quote:
With a 20% drug price discount applied to all biologics, the annual health plan costs for brodalumab, adalimumab, ustekinumab, secukinumab, ixekizumab, and etanercept were estimated at $37,224, $49,166, $55,084, $56,061, $64,396, and $57,170, respectively.


https://www.ncbi.nlm.nih.gov/pubmed/29357713

The annual health plan costs for brodalumab (SILIQ™) $37,224

The annual health plan costs for adalimumab (Humira) $49,166

The annual health plan costs for ustekinumab (STELARA®) $55,084

The annual health plan costs for secukinumab (Cosentyx) $56,061

The annual health plan costs for ixekizumab (Taltz) $64,396

The annual health plan costs for etanercept (Enbrel) $57,170

The annual health plan costs for apremilast (Otezla) $31,992

Based on:
Quote:
The average wholesale price for a 30-day supply (60 tablets) of apremi-last 30 mg is $2,666


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517531/

Good luck and GOD bless,

George

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News